Condition

Metastatic Prostate Neuroendocrine Carcinoma clinical trials and research

• 2Clinical trials
• 1Country

All recruiting trials (2)

• Detecting low PSMA prostate cancer using a special PET scan

  This study is testing a new type of PET scan to see if it can better detect advanced prostate cancer that has low PSMA levels or neuroendocrine features in patients.

  Recruiting at 2 sites Phase 1 Brigham and Women's Hospital · Boston, Massachusetts and 1 other locations · NCT06062745

• Testing a radioactive treatment for metastatic prostate cancer with neuroendocrine cells

  This study is testing a radioactive treatment to see if it can help people with metastatic prostate cancer that has neuroendocrine features feel better and live longer.

  Recruiting at 11 sites Phase 2 National Cancer Institute (NCI) · Duarte, California and 12 other locations · NCT05691465

Related topics

Quick answers

How many Metastatic Prostate Neuroendocrine Carcinoma clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →